Colon Cancer, Da Vinci Robot, Surgery
Conditions
Brief summary
The purpose of this study is to compare the clinical data of patients with colon cancer who received robotic or laparoscopic surgery, and to compare the short-term and long-term effects of robotic surgery in the treatment of colon cancer. To verify the safety and effectiveness of the corresponding surgical methods, and provide better guidance for the following clinical practice.
Interventions
PROCEDUREDa Vinci Robotic Surgery
Da Vinci Robotic Surgery
Sponsors
The First Hospital of Jilin University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Inclusion criteria
1. Age: 18-80 years old, male or female; 2. Colon cancer (ascending colon, transverse colon, descending colon, sigmoid colon) is diagnosed by histology or cytology; 3. The clinical stage is T1-4aN0-2M0; 4 No multiple distant metastases; 5\. ECOG score 0-2; 6. Heart, lung, liver, and kidney functions can tolerate surgery; 7. Patients and their families can understand and are willing to participate in this clinical study, and sign an informed consent.
Exclusion criteria
1. Past history of malignant colorectal tumors or recent diagnosis combined with other malignant tumors; 2. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. who need emergency surgery; 3. Neighboring organs need to be combined with organ resection; 4. New adjuvant therapy before surgery; 5. ASA grade ≥ grade IV and/or ECOG physical status score\> 2 points; 6. Those who have severe liver and kidney function, cardiopulmonary function, blood coagulation dysfunction, or combined with serious underlying diseases that cannot tolerate surgery; 7. Have a history of severe mental illness; 8. Pregnant or lactating women; 9. Patients with other clinical and laboratory conditions considered by the investigator should not participate in the trial.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of lymph nodes harvested | During the operation | Number of lymph nodes harvested |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of surgical incision | During the operation | Length of surgical incision |
| Intraoperative blood loss | During the operation | Intraoperative blood loss |
| Intraoperative concversion rate | During the operation | Intraoperative concversion rate |
| Operation time | During the operation | Operation time |
| 3-year disease-free survival | 3 years after surgery | 3-year disease-free survival |
| 5-year overall survival | 5 years after surgery | 5-year overall survival |
| Postoperative recovery | During the postoperative hospital stay | first exhaust, defecation time, restoring liquid diet, hospitalization days, etc. |
Countries
China
Outcome results
None listed